ORIC Pharmaceuticals (ORIC) Short Interest Ratio & Short Volume $5.87 +0.20 (+3.53%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$5.80 -0.07 (-1.19%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC Pharmaceuticals Short Interest DataORIC Pharmaceuticals (ORIC) has a short interest of 11.19 million shares. This marks a -15.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.2, indicating that it would take 11.2 days of the average trading volume of 652,571 shares to cover all short positions.Current Short Interest11,190,000 sharesPrevious Short Interest13,260,000 sharesChange Vs. Previous Month-15.61%Dollar Volume Sold Short$63.89 millionShort Interest Ratio11.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares71,088,000 sharesPercentage of Shares Shorted15.74%Today's Trading Volume1,186,240 sharesAverage Trading Volume652,571 sharesToday's Volume Vs. Average182% Short Selling ORIC Pharmaceuticals? Sign up to receive the latest short interest report for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORIC Short Interest Over TimeORIC Days to Cover Over TimeORIC Percentage of Float Shorted Over Time ORIC Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202511,190,000 shares $63.89 million -15.6%N/A11.2 $5.71 4/15/202513,260,000 shares $66.83 million -12.2%19.8%12.6 $5.04 3/31/202515,100,000 shares $84.26 million +8.1%22.5%14.1 $5.58 3/15/202513,970,000 shares $108.83 million +3.2%20.8%14.7 $7.79 2/28/202513,540,000 shares $108.73 million +12.5%20.2%15.3 $8.03 2/15/202512,040,000 shares $100.65 million +15.2%17.9%14.2 $8.36 1/31/202510,450,000 shares $108.89 million -0.7%N/A15.1 $10.42 1/15/202510,520,000 shares $114.35 million -8.0%N/A22.2 $10.87 12/31/202411,440,000 shares $92.32 million +2.1%N/A26.8 $8.07 12/15/202411,210,000 shares $95.51 million -0.7%N/A28.7 $8.52 Get the Latest News and Ratings for ORIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/202411,290,000 shares $111.77 million -1.5%N/A25.8 $9.90 11/15/202411,460,000 shares $97.41 million -1.6%N/A25.5 $8.50 10/31/202411,650,000 shares $109.28 million -2.9%N/A25.5 $9.38 10/15/202412,000,000 shares $114.24 million -2.1%N/A26.7 $9.52 9/30/202412,260,000 shares $125.67 million -1.0%N/A25 $10.25 9/15/202412,380,000 shares $122.44 million -2.3%N/A21 $9.89 8/31/202412,670,000 shares $131.39 million -1.5%N/A23.1 $10.37 8/15/202412,860,000 shares $139.27 million +7.9%N/A22.3 $10.83 7/31/202411,920,000 shares $133.50 million +4.8%N/A21.8 $11.20 7/15/202411,380,000 shares $122.34 million -2.7%N/A20.9 $10.75 6/30/202411,700,000 shares $82.72 million +4.4%N/A22.1 $7.07 6/15/202411,210,000 shares $83.96 million +3.3%N/A24.6 $7.49 5/31/202410,850,000 shares $97.54 million +2.2%N/A21.5 $8.99 5/15/202410,620,000 shares $98.87 million +3.7%N/A18.9 $9.31 4/30/202410,240,000 shares $90.42 million +8.7%N/A17.8 $8.83 4/15/20249,420,000 shares $89.87 million +15.7%N/A16.8 $9.54 3/31/20248,140,000 shares $111.93 million +17.5%N/A13.9 $13.75 3/15/20246,930,000 shares $104.64 million +6.8%N/A13 $15.10 2/29/20246,490,000 shares $82.68 million -0.8%N/A13.6 $12.74 2/15/20246,540,000 shares $73.58 million +0.9%N/A16.1 $11.25 1/31/20246,480,000 shares $71.22 million -25.6%N/A16.5 $10.99 1/15/20248,710,000 shares $74.91 million +0.1%28.0%19.8 $8.60 12/31/20238,700,000 shares $80.04 million +0.4%27.9%20.9 $9.20 12/15/20238,670,000 shares $80.72 million -2.8%27.8%18.7 $9.31 11/30/20238,920,000 shares $70.47 million +1.7%28.6%19 $7.90 11/15/20238,770,000 shares $57.27 million +14.9%28.1%20.3 $6.53 10/31/20237,630,000 shares $51.12 million +6.0%24.1%17.5 $6.70 10/15/20237,200,000 shares $40.07 million +4.8%22.7%18.9 $5.57 9/30/20236,870,000 shares $41.56 million +10.3%21.7%20 $6.05 9/15/20236,230,000 shares $51.71 million +2.1%19.7%18.1 $8.30AI Meltdown Imminent: Dump These Stocks Now! (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 8/31/20236,100,000 shares $54.66 million +3.6%19.2%14.9 $8.96 8/15/20235,890,000 shares $51.42 million +1.2%18.6%13.7 $8.73 7/31/20235,820,000 shares $48.66 million -2.0%21.5%15 $8.36 7/15/20235,940,000 shares $46.27 million No Change22.0%15.7 $7.79 6/30/20235,940,000 shares $46.09 million +19.5%19.0%17 $7.76 6/15/20234,970,000 shares $31.96 million +15.1%15.9%15.4 $6.43 5/31/20234,320,000 shares $21.77 million +0.9%13.8%23.1 $5.04 5/15/20234,280,000 shares $22.13 million +0.9%13.7%27.5 $5.17 4/30/20234,240,000 shares $21.92 million No Change13.6%24.4 $5.17 4/15/20234,240,000 shares $25.61 million +1.7%13.6%22.6 $6.04 3/31/20234,170,000 shares $23.77 million +2.0%14.3%18.4 $5.70 3/15/20234,090,000 shares $17.71 million -1.5%14.1%4.1 $4.33 2/28/20234,150,000 shares $18.38 million No Change16.3%4.2 $4.43 2/15/20234,150,000 shares $19.92 million -2.8%16.3%4.2 $4.80 1/31/20234,270,000 shares $24.17 million +11.2%16.8%4.4 $5.66 1/15/20233,840,000 shares $22.73 million +8.5%15.1%4.1 $5.92 12/30/20223,540,000 shares $20.85 million +45.1%14.0%3.9 $5.89 12/15/20222,440,000 shares $7.93 million -1.2%8.0%3.1 $3.25 11/30/20222,470,000 shares $8.87 million -6.4%8.1%25.6 $3.59 11/15/20222,640,000 shares $9.27 million -0.4%8.7%28.2 $3.51 10/31/20222,650,000 shares $7.08 million -0.8%8.7%31.7 $2.67 10/15/20222,670,000 shares $7.40 million -1.1%8.8%23.9 $2.77 9/30/20222,700,000 shares $8.64 million No Change8.9%22.2 $3.20 9/15/20222,700,000 shares $9.07 million +1.1%8.9%12.5 $3.36 8/31/20222,670,000 shares $9.24 million -3.3%8.8%11.3 $3.46 8/15/20222,760,000 shares $13.00 million -0.7%9.1%9.7 $4.71 7/31/20222,780,000 shares $10.17 million -2.1%9.2%7.7 $3.66 7/15/20222,840,000 shares $12.13 million -6.6%9.4%7.2 $4.27 6/30/20223,040,000 shares $13.62 million -30.3%10.0%6.6 $4.48 6/15/20224,360,000 shares $17.35 million -2.5%14.4%7.5 $3.98 5/31/20224,470,000 shares $14.93 million -8.4%15.3%6.4 $3.34 5/15/20224,880,000 shares $13.71 million +38.6%16.7%7.2 $2.81 4/30/20223,520,000 shares $11.69 million +32.3%11.6%5.6 $3.32 4/15/20222,660,000 shares $11.97 million +4.3%8.8%4.4 $4.50 3/31/20222,550,000 shares $13.62 million -23.9%8.4%4.7 $5.34 3/15/20223,350,000 shares $20.50 million -4.3%10.8%8.2 $6.12 2/28/20223,500,000 shares $27.16 million +10.4%11.3%16.6 $7.76 2/15/20223,170,000 shares $28.56 million +12.0%10.3%15.9 $9.01 1/31/20222,830,000 shares $27.99 million +14.1%9.2%15.2 $9.89 1/15/20222,480,000 shares $31.74 million -6.4%8.0%14.6 $12.80 12/31/20212,650,000 shares $38.96 million -7.3%8.6%15 $14.70 12/15/20212,860,000 shares $36.87 million +1.4%9.3%10.8 $12.89 11/30/20212,820,000 shares $39.03 million -3.4%9.1%10.3 $13.84 11/15/20212,920,000 shares $51.22 million +0.3%9.5%10.7 $17.54 10/29/20212,910,000 shares $42.60 million -1.4%9.8%10.3 $14.64 10/15/20212,950,000 shares $47.88 million -2.0%9.9%10.9 $16.23 9/30/20213,010,000 shares $62.94 million -2.0%10.1%10.8 $20.91 9/15/20213,070,000 shares $76.93 million -5.0%10.3%14 $25.06 8/31/20213,230,000 shares $71.35 million -3.6%10.8%15.5 $22.09 8/13/20213,350,000 shares $62.41 million -0.3%11.2%15.4 $18.63The Secret Map of America, Declassified… (Ad)Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “secret America” — an America first envisioned by President Harry Truman in 1946, and then classified by the government for decades. Click here to view the secret map now >> 7/30/20213,360,000 shares $55.94 million +6.7%11.5%15.8 $16.65 7/15/20213,150,000 shares $60.95 million -42.8%10.8%14.1 $19.35 6/30/20215,510,000 shares $97.47 million -2.7%18.9%25.3 $17.69 6/15/20215,660,000 shares $106.41 million +3.1%19.4%27.4 $18.80 5/28/20215,490,000 shares $125.45 million -1.6%18.9%24.3 $22.85 5/14/20215,580,000 shares $135.26 million +1.6%19.2%25 $24.24 4/30/20215,490,000 shares $135.49 million +3.8%19.2%24 $24.68 4/15/20215,290,000 shares $112.62 million +11.4%18.5%22.1 $21.29 3/31/20214,750,000 shares $112.43 million +31.6%16.8%16.3 $23.67 3/15/20213,610,000 shares $110.36 million +4.3%12.8%11.2 $30.57 2/26/20213,460,000 shares $120.68 million +1.2%15.1%11.4 $34.88 2/12/20213,420,000 shares $112.93 million -1.2%15.0%10.9 $33.02 1/29/20213,460,000 shares $105.53 million +21.4%12.3%9.8 $30.50 1/15/20212,850,000 shares $95.48 million No Change10.2%8.3 $33.50 ORIC Short Interest - Frequently Asked Questions What is ORIC Pharmaceuticals' current short interest? Short interest is the volume of ORIC Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 11,190,000 shares of ORIC short. Learn More on ORIC Pharmaceuticals' current short interest. What is a good short interest ratio for ORIC Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORIC shares currently have a short interest ratio of 11.0. Learn More on ORIC Pharmaceuticals's short interest ratio. Which institutional investors are shorting ORIC Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ORIC Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ORIC Pharmaceuticals' short interest increasing or decreasing? ORIC Pharmaceuticals saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 11,190,000 shares, a decrease of 15.6% from the previous total of 13,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ORIC Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ORIC Pharmaceuticals: Evotec SE (0.21%), Immunocore Holdings plc (16.29%), Mesoblast Limited (2.10%), Adaptive Biotechnologies Co. (6.02%), Vera Therapeutics, Inc. (12.17%), Dyne Therapeutics, Inc. (13.07%), Structure Therapeutics Inc. (16.78%), ANI Pharmaceuticals, Inc. (9.23%), ARS Pharmaceuticals, Inc. (29.82%), 89bio, Inc. (11.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short ORIC Pharmaceuticals stock? Short selling ORIC is an investing strategy that aims to generate trading profit from ORIC Pharmaceuticals as its price is falling. ORIC shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ORIC Pharmaceuticals? A short squeeze for ORIC Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORIC, which in turn drives the price of the stock up even further. How often is ORIC Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORIC, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies EVO Short Interest IMCR Short Interest MESO Short Interest ADPT Short Interest VERA Short Interest DYN Short Interest GPCR Short Interest ANIP Short Interest SPRY Short Interest ETNB Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORIC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ORIC Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORIC Stock Free ORIC Stock Alerts